Cargando…
Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review
Preparations from Crataegus (hawthorn) have a long history in the treatment of heart failure. WS 1442 is a dry extract from hawthorn leaves with flowers (4–6.6:1), extraction solvent of ethanol 45% (w/w), adjusted to 17.3–20.1% of oligomeric procyanidins. Nonclinical studies show that WS 1442 has po...
Autores principales: | Holubarsch, Christian J. F., Colucci, Wilson S., Eha, Jaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772138/ https://www.ncbi.nlm.nih.gov/pubmed/29080984 http://dx.doi.org/10.1007/s40256-017-0249-9 |
Ejemplares similares
-
Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
por: Halver, Jonas, et al.
Publicado: (2019) -
SAFETY AND EFFECTS OF CRATAEGUS EXTRACT WS 1442 AND NORDIC WALKING ON LIPID PROFILE AND ENDOTHELIAL FUNCTION: A RANDOMIZED, PARTIALLY BLINDED PILOT STUDY IN OVERWEIGHT VOLUNTEERS
por: Niederseer, David, et al.
Publicado: (2019) -
Nanomechanics and Sodium Permeability of Endothelial Surface Layer Modulated by Hawthorn Extract WS 1442
por: Peters, Wladimir, et al.
Publicado: (2012) -
Correction: Nanomechanics and Sodium Permeability of Endothelial Surface Layer Modulated by Hawthorn Extract WS 1442
por: Peters, Wladimir, et al.
Publicado: (2013) -
Sphenoid Sinus Diseases: A Review of 1,442 Patients
por: Fooanant, Supranee, et al.
Publicado: (2017)